Literature DB >> 16377837

Systemic hemostasis with recombinant-activated factor VII followed by local thrombolysis with recombinant tissue plasminogen activator in intraventricular hemorrhage.

Catalina C Ionita1, Joseph Ferrara, David L McDonagh, Peter Grossi, Carmelo Graffagnino.   

Abstract

INTRODUCTION: A 51-year-old woman on warfarin thromboprophylaxis for transient ischemic attacks developed sudden onset nausea, vomiting, and decreased mental status, rapidly becoming comatose. Head computed tomography (CT) showed intracerebral hemorrhage, extending into all ventricular chambers, and acute obstructive hematocephalus requiring urgent ventricular drainage. CT angiogram showed no evidence of an aneurysm or vascular malformation.
METHODS: The pretreatment international normalized ratio (INR) of 4.9 was rapidly corrected with recombinant activated factor VII and an external ventricular drain was placed. Despite accurate positioning, the ventriculostomy thrombosed and became nonfunctional. Recombinant tissue plasminogen activator was given intraventricularly and resulted in partial ventricular decompression within 24 hours, with dramatic improvement in the patient's level of consciousness.
RESULTS: Repeated intraventricular fibrinolysis resulted in further reduction of the intraventricular hematoma within a few days and a good patient outcome. The patient did not require permanent ventricular shunt.
CONCLUSION: To our knowledge, this is the first reported case of combined systemic enhancement of hemostasis and local fibrinolysis as a life-saving measure in intracranial hemorrhage.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16377837     DOI: 10.1385/NCC:3:3:246

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  12 in total

1.  Treatment of severe intraventricular hemorrhage by intraventricular infusion of urokinase.

Authors:  T Todo; M Usui; K Takakura
Journal:  J Neurosurg       Date:  1991-01       Impact factor: 5.115

2.  Recombinant factor VIIa for rapid reversal of warfarin anticoagulation in acute intracranial hemorrhage.

Authors:  William D Freeman; Thomas G Brott; Kevin M Barrett; Pablo R Castillo; H Gordon Deen; Leo F Czervionke; James F Meschia
Journal:  Mayo Clin Proc       Date:  2004-12       Impact factor: 7.616

Review 3.  Ongoing NovoSeven trials.

Authors:  Elisabeth Erhardtsen
Journal:  Intensive Care Med       Date:  2002-10       Impact factor: 17.440

4.  Volume of ventricular blood is an important determinant of outcome in supratentorial intracerebral hemorrhage.

Authors:  S Tuhrim; D R Horowitz; M Sacher; J H Godbold
Journal:  Crit Care Med       Date:  1999-03       Impact factor: 7.598

5.  Cohort study of intraventricular thrombolysis with recombinant tissue plasminogen activator for aneurysmal intraventricular hemorrhage.

Authors:  J Max Findlay; Michael J Jacka
Journal:  Neurosurgery       Date:  2004-09       Impact factor: 4.654

6.  The safety and efficacy of recombinant human blood coagulation factor IX in previously untreated patients with severe or moderately severe hemophilia B.

Authors:  Amy D Shapiro; Jorge Di Paola; Alice Cohen; K John Pasi; Margaret A Heisel; Victor S Blanchette; Thomas C Abshire; W Keith Hoots; Jeanne M Lusher; Claude Negrier; Chantal Rothschild; David A Roth
Journal:  Blood       Date:  2004-09-21       Impact factor: 22.113

7.  Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage.

Authors:  J J Flibotte; N Hagan; J O'Donnell; S M Greenberg; J Rosand
Journal:  Neurology       Date:  2004-09-28       Impact factor: 9.910

8.  Primary intraventricular hemorrhage in adults: clinical features, risk factors, and outcome.

Authors:  M Angelopoulos; S R Gupta; B Azat Kia
Journal:  Surg Neurol       Date:  1995-11

9.  Intraventricular recombinant tissue plasminogen activator for lysis of intraventricular haemorrhage.

Authors:  V Rohde; C Schaller; W E Hassler
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-04       Impact factor: 10.154

10.  Intraventricular thrombolysis speeds blood clot resolution: results of a pilot, prospective, randomized, double-blind, controlled trial.

Authors:  Neal J Naff; Daniel F Hanley; Penelope M Keyl; Stanley Tuhrim; Michael Kraut; Joshua Bederson; Ross Bullock; Stephan A Mayer; Eric Schmutzhard
Journal:  Neurosurgery       Date:  2004-03       Impact factor: 4.654

View more
  1 in total

Review 1.  Intraventricular fibrinolysis for intracerebral hemorrhage with severe ventricular involvement.

Authors:  Dimitre Staykov; Juergen Bardutzky; Hagen B Huttner; Stefan Schwab
Journal:  Neurocrit Care       Date:  2011-08       Impact factor: 3.210

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.